Ashland (ASH) AI Stock Analysis

Ashland

(BMV:ASH)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Recurring qualified-input demandAshland’s ingredients become qualified inputs in customer formulations and production processes, which can make replacement costly and support repeat purchasing. This embedded role, combined with technical assistance and application support, strengthens customer retention and gives differentiated products more durable revenue potential.

Negative Factors

Volatile profitabilityThe sharp move from a substantial FY2025 loss to modest TTM profitability shows that Ashland’s earnings base remains inconsistent. With only about a 4% TTM net margin, relatively small changes in production, costs, pricing, or mix could materially affect profits and reduce confidence in sustained returns.

Ashland Business Overview & Revenue Model

Company Description

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Lif...

Ashland Earnings Call Summary

Earnings Call Date:Jul 27, 2026(Q3-2026)|Next Earnings Date:Nov 02, 2026

Earnings Call SentimentNeutral

The call presented a mix of clear commercial and cash-generation strengths—broad-based revenue growth (7% YoY), strong Life Sciences and Personal Care performance, inventory reduction, improved liquidity and the successful execution of Globalize and Innovate initiatives—while also acknowledging material margin pressure from earlier production disruptions, lower adjusted EBITDA versus last year, EPS headwinds from a higher tax rate, and slower-than-expected operational improvements in certain plants (notably Hopewell/HEC). Management expects pricing realization and manufacturing improvements to support a step-up in profitability in Q4 and reaffirmed revenue and EBITDA guidance, but timing of full margin recovery remains uncertain.

Positive Updates

Revenue Growth and Volume Expansion

Third quarter sales of $497 million, up 7% year-over-year; volumes increased 6% across the portfolio, with foreign exchange contributing approximately $3 million (~1%).

Negative Updates

Adjusted EBITDA and Margin Pressure

Adjusted EBITDA declined to $109 million from $113 million year-over-year; adjusted EBITDA margin fell to 21.9% from 24.4% (a drop of ~250 basis points), reflecting operational disruptions and incentive normalization.

Company Guidance

Management reaffirmed fiscal 2026 guidance calling for sales of $1.835–$1.870 billion and adjusted EBITDA of $385–$400 million, said Q4 should see a further step-up in profitability as pricing realization and operational improvements continue, and revised adjusted EPS guidance to low- to mid‑single‑digit growth (down from prior mid‑ to high‑single‑digit) due to a higher tax rate from discrete items; they also reiterated expected free cash flow conversion of >50% of adjusted EBITDA for the year. Key near‑term and program metrics cited on the call included Q3 sales of $497 million (+7% y/y) with volumes +6% and pricing ~+1% y/y, Q3 adjusted EBITDA of $109 million (21.9% margin) and adjusted EPS excluding amortization of $1.20, free cash flow of $103 million (conversion above 90% for the quarter), available liquidity of $936 million and net leverage of 2.4x, inventory down nearly $80 million YTD, pricing run‑rate targets in the ~3–8% range (tracking the midpoint), and structural run‑rate savings of roughly $12 million from VP&D optimization plus ~$3 million from small‑plant consolidation (≈$15 million total this year).

Ashland Risk Analysis

Ashland disclosed 18 risk factors in its most recent earnings report. Ashland reported the most risks in the "Production" category.

Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Ashland Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MX:ASH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IOSP	76Outperform	$2.46B	20.27	9.15%	1.80%	2.87%	534.76%
FUL	68Neutral	$2.68B	14.16	9.51%	1.88%	1.48%	72.33%
EMN	65Neutral	$7.61B	11.78	10.63%	5.03%	0.40%	-6.58%
ESI	62Neutral	$8.31B	40.39	7.39%	0.94%	39.62%	-14.83%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SCL	61Neutral	$1.58B	370.00	0.36%	2.25%	10.02%	-90.50%

* Basic Materials Sector Average

Performance Comparison

MX:ASH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
EMN	Eastman Chemical Company	66.78	8.93	15.44%
FUL	H.B. Fuller Company	51.56	-4.69	-8.34%
IOSP	Innospec	99.55	28.16	39.45%
SCL	Stepan Company	70.30	29.26	71.28%
ESI	Element Solutions	34.14	7.37	27.51%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Ashland AI Stock Analysis